Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac + Capsaicin Gel in Acute Back/Neck Pain
NCT02700815Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of diclofenac and capsaicin in acute lumbago (4 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Change in Pain on Movement (POM) Between Baseline and Day 2 Evening. Started May 2016; status: completed.
02
Drugs
diclofenaccapsaicin
03
Conditions
acute lumbago
Beyond the preview
Go deeper on NCT02700815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02700815.